Glucocorticoids, feto-placental 11β-hydroxysteroid dehydrogenase type 2, and the early life origins of adult disease

Steroids

Volumn 62, Issue 1, 1997, Pages 89-94

  Seckl, Jonathan R ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

corticosterone; cortisol; dexamethasone; fet us; growth; hyper tension; non insulin dependent diabetes mellitus; placenta; programming

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; CORTICOSTERONE; DEXAMETHASONE; HYDROCORTISONE; ISOENZYME;

CONFERENCE PAPER; FETOPLACENTAL UNIT; FETUS DEVELOPMENT; HUMAN; HYPERTENSION; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK FACTOR; STEROID METABOLISM;

EID: 0031030590     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-128X(96)00165-1     Document Type: Conference Paper

References (88)

1. Barker DJP (1991). Fetal and Infant Origins of Adult Disease. BMJ, London.
2. Barker DJP, Gluckman PD, Godfrey KM, Harding JE, Owens JA, Robinson JS (1993). Fetal nutrition and cardiovascular disease in adult life. Lancet 341:938-941.
3. Barker DJP, Hales CN, Fall CHD, Osmond C, Phipps K, Clarke PMS (1993). Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia 36:62-67.
4. Yajnik CS, Fall CHD, Vaidya U, Pandit AN, Bavedekar A, Bhat DS, Osmond C, Hales CN, Barker DJP (1995). Fetal growth and glucose and insulin metabolism in four-year-old Indian children. Diabetic Med 12:330-336.
5. Levine RS, Hennekens CH, Jesse MJ (1994). Blood pressure in prospective population based cohort of newborn and infant twins. Br Med J 308:298-302.
6. Barker DJP (1994). Mothers, Babies, and Disease in Later Life. BMJ Publishing Group, London.
7. Barker DJP, Osmond C, Goldings J, Kuh D, Wadsworth MEJ (1989). Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. Br Med J 298:564-567.
8. Whelan TB, Schteingart DE, Starkman MN, Smith A (1980). Neuropsychological deficits in Cushing's syndrome. J Nerv Ment Dis 22:752-757.
9. Osmond C, Barker DJP, Winter PD, Fall CHD, Simmonds SJ (1993). Early growth and death from cardiovascular disease in women. Br Med J 307:1524-1527.
10. Leon DA, Koupilova I, Lithell HO, Berglund L, Mohsen R, Vagero D, Lithell UB, McKeigue PM (1996). Failure to realise growth potential in utero and adult obesity in relation to blood pressure in 50 year old Swedish men. Br Med J 312:401-406.
11. Edwards CRW, Benediktsson R, Lindsay R, Seckl JR (1993). Dysfunction of the placental glucocorticoid barrier: a link between the foetal environment and adult hypertension. Lancet 341:355-357.
12. Gustafsson J-A, Mode A, Norstedt G, Skett P (1983). Sex steroid-induced changes in hepatic enzymes. Annu Rev Physiol 45:51-60.
13. Seckl JR (1994). Glucocorticoids and small babies. Q J Med 87: 259-262.
14. Gustafsson JA, Stenberg A (1974). Irreversible androgenic programming at birth of microsomal and soluble rat liver enzymes active on 4-androstene-3,17-dione and 5-alpha-, androstane-3-alpha, 17-beta-diol. J Biol Chem 249:711-718.
15. Arai Y, Gorski RA (1968). Critical exposure time for androgenization of the developing hypothalamus in the female rat. Endocrinology 82:1010-1014.
16. Reinisch JM, Simon NG, Karwo WG, et al. (1978). Prenatal exposure to prednisone in humans and animals retards intra-uterine growth. Science 202:436-438.
17. Novy MJ, Walsh SW (1983). Dexamethasone and estradiol treatment in pregnant rhesus macaques: effects on gestation length, maternal plasma hormones and fetal growth. Am J Obstet Gynecol 145:920-930.
18. Mosier HD Jr, Dearden LC, Jansons RA, Roberts RC, Biggs CS (1982). Disproportionate growth of organs and body weight following glucocorticoid treatment of the rat fetus. Dev Pharmacol Ther 4:89-105.
19. Goland RS, Jozak S, Warren WB, Conwell IM, Stark RI, Tropper PJ (1993). Elevated levels of umbilical cord plasma corticotropin-releasing hormone in growth-related fetuses. J Clin Endocrinol Metab 77:1174-1179.
20. Gunberg DL (1957). Some effects of exogenous hydrocortisone on pregnancy in the rat. Anat Res 129:133-153.
21. Tonolo G, Fraser R, Connell JMC, Kenyon CJ (1988). Chronic low-dose infusions of dexamethasone in rats: effect on blood pressure, body weight and plasma atrial natriuretic peptide. J Hypertens 6:25-31.
22. Tangalakis K, Lumbers ER, Moritz KM, Towstoless MK, Wintour EM (1992). Effect of cortisol on blood pressure and vascular reactivity in the ovine fetus. Exp Physiol 77:709-717.
23. Kari MA, Hallman M, Eronen M, Teramo K, Virtanen M, Koivisto M, Ikonen RS (1994). Prenatal dexamethasone treatment in conjunction with rescue therapy of human surfactant: a randomized placebo-controlled multicenter study. Pediatrics 93:730-736.
24. Meaney MJ, Aitken DH, Viau V, Sharma S, Sarrieau A (1989). Neonatal handling alters adrenocortical negative feedback sensitivity and hippocampal type II glucocorticoid receptor binding in the rat. Neuroendocrinology 50:597-604.
25. Levine S (1957). Infantile experience and resistance to physiological stress. Science 126:405-406.
26. Henry C, Kabbaj M, Simon H, Le Moal M, Maccari S (1994). Prenatal stress increases the hypothalamo-pituitary-adrenal axis response in young and adult rats. J Neuroendocrinol 6:341-345.
27. Catalani A, Marinelli M, Scaccianoce S, Nicolai R, Muscolo LAA, Porcu A, Koranyi L, Piazza PV, Angelucci L (1993). Progeny of mothers drinking corticosterone during lactation has lower stress-induced corticosterone secretion and better cognitive performance. Brain Res 624:209-215.
28. Diaz R, Ögren SO, Blum M, Fuxe K (1995). Prenatal corticosterone increases spontaneous and d-amphetamine induced locomotor activity and brain dopamine metabolism in prepubertal male and female rats. Neuroscience 66:467-473.
29. Weinstock M, Matlina E, Maor GI, Rosen H, McEwen BS (1992). Prenatal stress selectively alters the reactivity of the hypothalamic-pituitary adrenal system in the female rat. Brain Res 595:195-200.
30. Redei E, Halasz I, Li LF, Prystowsky MB, Aird F (1993). Maternal adrenalectomy alters the immune and endocrine functions of fetal alcohol-exposed male offspring. Endocrinology 133:452-460.
31. O'Donnell D, La Roque S, Seckl JR, Meaney M (1994). Postnatal handling alters glucocorticoid but not mineralocorticoid receptor mRNA expression in the hippocampus of adult rats. Mol Brain Res 26:242-248.
32. Jacobson L, Sapolsky R (1991). The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenal axis. Endocr Rev 12:118-134.
33. Smythe JW, Rowe WB, Meaney MJ (1994). Neonatal handling alters serotonin (5-HT) turnover and 5-HT2 receptor binding in selected brain regions: relationship to the handling effect on glucocorticoid receptor expression. Dev Brain Res 80:183-189.
34. Mitchell JB, Betito K, Boksa P, Rowe W, Meaney MJ (1992). Serotonergic regulation of type II corticosteroid receptor binding in cultured hippocampal cells: the role of serotonin-induced increases in cAMP levels. Neuroscience 48:631-639.
35. Diorio J, Donaldson L, Yau J, Sharma S, Seckl JR, Meaney MJ (1994). Postnatal handling alters AP-2, NGFI-A and NGFI-B mRNA expression in rat hippocampus. Soc Neurosci Abstr 20:1317.
36. Cole T, Blendy JA, Monaghan AP, Kriegelstein K, Schmid W, Fantuzzi G, Hummler E, Unsicker K, Schütz G (1995). Targeted disruption of the glucocorticoid receptor blocks adrenergic chromaffin cell development and severely retards lung maturation. Genes Dev 9:1608-1621.
37. Seckl JR, Olsson T (1995). Glucocorticoids and the age-impaired hippocampus: cause or effect? J Endocrinol 145:201-211.
38. Benediktsson R, Lindsay R, Noble J, Seckl JR, Edwards CRW (1993). Glucocorticoid exposure in utero: a new model for adult hypertension. Lancet 341:339-341.
39. Beitens IZ, Bayard F, Ances IG, Kowarski A, Migeon CJ (1973). The metabolic clearance rate, blood production, interconversion and transplacental passage of cortisol and cortisone in pregnancy near term. Pediatr Res 7:509-519.
40. Campbell AL, Murphy BEP (1977). The maternal-fetal cortisol gradient during pregnancy and at delivery. J Clin Endocrinol Metab 45:435-440.
41. Murphy BEP, Clark SJ, Donald IR, Pinsky M, Vedady DL (1974). Conversion of maternal cortisol to cortisone during placental transfer to the human fetus. Am J Obstet Gynecol 118:538-541.
42. Lopez-Bernal A, Flint APF, Anderson ABM, Turnbull AC (1980). 11β-Hydroxysteroid dehydrogenase activity (E.C.1.1.1.146) in human placenta and decidua. J Steroid Biochem 13:1081-1087.
43. Seckl JR (1993). 11β-Hydroxysteroid dehydrogenase isoforms and their implications for blood pressure regulation. Eur J Clin Invest 23:589-601.
44. Edwards CRW, Stewart PM, Burt D, Brett L, McIntyre MA, Sutanto WS, de Kloet ER, Monder C (1988). Localisation of 11β-hydroxysteroid dehydrogenase-tissue specific protector of the mineralocorticoid receptor. Lancet ii:986-989.
45. Funder JW, Pearce PT, Smith R, Smith AI (1988). Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science 242:583-585.
46. Krozowski ZK, Funder JW (1983). Renal mineralocorticoid receptors and hippocampal corticosterone binding species have identical intrinsic steroid specificity. Proc Natl Acad Sci USA 80:6056-6060.
47. Arriza JL, Weinberger C, Cerelli G, Glaser TM, Handelin BL, Housman DE, Evans RM (1987). Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science 237:268-275.
48. Brown RW, Kotolevtsev Y, Leckie C, Lindsay RS, Lyons V, Murad P, Mullins JJ, Chapman KE, Edwards CRW, Seckl JR (1996). Isolation and cloning of human placental 11β-hydroxysteroid dehydrogenase-2 cDNA. Biochem J 313:1007-1017.
49. Stewart PM, Valentino R, Wallace AM, Burt D, Shackleton CHL, Edwards CRW (1987). Mineralocorticoid activity of liquorice: 11β-hydroxysteroid dehydrogenase deficiency comes of age. Lancet ii: 821-824.
50. Stewart PM, Corrie JET, Shackleton CHL, Edwards CRW (1988). Syndrome of apparent mineralocorticoid excess: a defect in the cortisol-cortisone shuttle. J Clin Invest 82:340-349.
51. Mune T, Rogerson FM, Nikkilä H, Agarwal AK, White PC (1995). Human hypertension caused by mutations in the kidney isozyme of 11β-hydroxysteroid dehydrogenase. Nature Genet 10:394-399.
52. Stewart PM, Rogerson FM, Mason JI (1995). Type 2 11β-hydroxysteroid dehydrogenase messenger RNA and activity in human placenta and fetal membranes: its relationship to birth weight and putative role in fetal steroidogenesis. J Clin Endocrinol Metab 80:885-890.
53. Rogerson FM, Kayes K, White PC (1996). No correlation in human placenta between activity or mRNA for the K (type 2) isozyme of 11β-hydroxysteroid dehydrogenase and fetal or placental weight. Tenth International Congress of Endocrinology Abstracts, Abstr. P1-231, p. 193.
54. Benediktsson R, Brennand J, Tibi L, Calder AA, Seckl JR, Edwards CRW (1995). Fetal osteocalcin levels are related to placental 11β-hydroxysteroid dehydrogenase activity. Clin Endocrinol 42:551-555.
55. Albiston AL, Obeyesekere VR, Smith RE, Krozowski ZS (1994). Cloning and tissue distribution of the human 11β-hydroxysteroid dehydrogenase type 2 enzyme. Mol Cell Endocrinol 105:R11-R17.
56. Brown RW, Chapman KE, Kotolevtsev Y, Yau JLW, Leckie C, Murad P, Lyons V, Edwards CRW, Seckl JR (1995). Isolation and cloning of human placental 11β-hydroxysteroid dehydrogenase-2 cDNA. J Endocrinol 144(suppl):OC35.
57. Lindsay RS, Lindsay RM, Edwards CRW, Seckl JR (1996). Inhibition of 11β-hydroxysteroid dehydrogenase in pregnant rats and the programming of blood pressure in the offspring. Hypertension 27:1200-1204.
58. Lindsay RS, Lindsay RM, Edwards CRW, Seckl JR (1995). Prenatal carbenoxolone, placental 11β-hydroxysteroid dehydrogenase and the programing of blood pressure and insulin resistance. 77th Annual Meeting of the Endocrine Society, Abstr. 2-494, p. 414.
59. Langley SC, Jackson AA (1994). Increased systolic blood pressure in adult rats induced by fetal exposure to maternal low protein diets. Clin Sci 86:217-222.
60. Jamieson PM, Chapman KE, Edwards CRW, Seckl JR (1995). 11β-Hydroxysteroid dehydrogenase is an exclusive 11β-reductase in primary cultured rat hepatocytes: effect of physicochemical and hormonal manipulations. Endocrinology 136:4754-4761.
61. Hundertmark S, Buhler H, Ragosch V, Dinkelborg L, Arabin B, Weitzel HK (1995). Correlation of surfactant phosphatidylcholine synthesis and 11beta-hydroxysteroid dehydrogenase in the fetal lung. Endocrinology 136:2573-2578.
62. Rajan V, Edwards CRW, Seckl JR (1996). 11β-hydroxysteroid dehydrogenase in cultured hippocampal cells reactivates inert 11-dehydrocorticosterone, potentiating neurotoxicity. J Neurosci 16: 65-70.
63. Jamieson PM, Chapman KE, Walker BR, Seckl JR (1996). Hepatic 11β-oxidoreductase (11β-HSD-1) enhances glucocorticoid-regulated gene transcription in the rat in vivo by reactivating inert glucocorticoid metabolites. J Endocrinol 148:44.
64. Walker BR, Connacher AA, Lindsay RM, Webb DJ, Edwards CRW (1995). Carbenoxolone increases hepatic insulin sensitivity in man: a novel role for 11-oxosteroid reductase in enhancing glucocorticoid receptor activation. J Clin Endocrinol Metab 80:3155-3159.
65. Brown RW, Diaz R, Robson AC, Kotolevtsev Y, Mullins JJ, Kaufman MH, Seckl JR (1996). The ontogeny of 11β-hydroxysteroid dehydrogenase type 2 and mineralocorticoid receptor gene expression reveal intricate control of glucocorticoid action in development. Endocrinology 137:794-797.
66. Stewart PM, Murry BA, Mason JI (1994). Type 2 11β-hydroxysteroid dehydrogenase in human fetal tissues. J Clin Endocrinol Metab 78:1529-1532.
67. Levitt N, Lindsay RS, Holmes MC, Seckl JR (1995). Prenatal dexamethasone programmes attenuated hippocampal glucocorticoid receptor gene expression and elevated basal corticosterone levels in adult life. 77th American Endocrine Society Abstracts, Abstr. 1-451, p. 225.
68. Baggia S, Albrecht E, Pepe G (1990). Regulation of 11β-hydroxysteroid dehydrogenase activity in the baboon placenta by estrogen. Endocrinology 126:2742-2748.
69. Waddell BJ, Bendiktsson R, Brown RW, Seckl JR (1996). Placental 11β-hydroxysteroid dehydrogenase-2 in the rat: kinetic analysis, gene expression and effects of fetectomy. Tenth International Congress of Endocrinology Abstracts, Abstr. P3-434, p. 863.
70. Meaney MJ, O'Donnell D, Viau V, Bhatnagar S, Sarrieau A, Smythe J, Shanks N, Walker C-D (1993). In: Growth Factors and Hormones, S. Zagon and PJ McLaughlin (eds). Chapman and Hall, New York, pp. 163-201.
71. Plotsky PM, Meaney MJ (1993). Early, postnatal experience alters hypothalamic corticotropin-releasing factor (CRF) mRNA, median eminence CRF content and stress-induced release in adult rats. Mol Brain Res 18:195-200.
72. Reul JMHM, Stec I, Wiegers GJ, Labeur MS, Linthorst ACE, Artz E, Holsboer F (1994). Prenatal immune challenge alters the hypothalamic-pituitary-adrenocortical axis in adult rats. J Clin Invest 93:2600-2607.
73. Maccari S, Piazza PV, Kabbaj M, Barbazanges A, Simon H, Le Moal M (1995). Adoption reverses the long-term impairment in glucocorticoid feedback induced by prenatal stress. J Neurosci 15: 110-116.
74. Huff RA, Seidler FJ, Slotkin TA (1991). Glucocorticoids regulate the ontogenic transition of adrenergic receptor subtypes in rat liver. Life Sci 48:1059-1065.
75. Bian XP, Seidler FJ, Slotkin TA (1992). Promotional role for glucocorticoids in the development of intracellular signalling: enhanced cardiac and renal adenylate cyclase reactivity to β-adrenergic and non-adrenergic stimuli after low-dose fetal dexamethasone exposure. J Dev Physiol 17:289-297.
76. Bian XP, Seidler FJ, Slotkin TA (1993). Fetal dexamethasone exposure interferes with establishment of cardiac noradrenergic innervation and sympathetic activity. Teratology 47:109-117.
77. Navarro HA, Kudlacz EM, Eylers JP, Slotkin TA (1989). Prenatal dexamethasone administration disrupts the pattern of cellular development in rat lung. Teratology 40:433-438.
78. Meaney MJ, Aitken DH, Sharma S, Viau V (1992). Basal ACTH, corticosterone and corticosterone-binding globulin levels over the diurnal cycle, and hippocampal corticosteroid receptors in young and aged, handled and non-handled rats. Neuroendocrinology 55: 204-213.
79. Friedman JE, Yun JS, Patel YM, McGrane MM, Hanson RW (1993). Glucocorticoids regulate the induction of phosphoenol pyruvate carboxykinase (GTP) gene transcription during diabetes. J Biol Chem 268:12952-12957.
80. Jones JI, Clemmons DR (1995). Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16:3-34.
81. Price WA, Stiles AD, Moats-Staats BM, D'Ercole AJ (1992). Gene expression of the insulin-like growth factors (IGFs), the type 1 IGF receptor, and IGF-binding proteins in dexamethasone-induced fetal growth retardation. Endocrinology 130:1424-1432.
82. Li J, Saunders JC, Gilmour RS, Fowden AL (1993). Insulin-like growth factor-II messenger RNA expression in fetal tissues of the sheep during late gestation: effects of cortisol. Endocrinology 132: 2083-2089.
83. Uno H, Eisele S, Sakai A, Shelton S, Baker E, DeJesus O, Holden J (1994). Neurotoxicity of glucocorticoids in the primate brain. Horm Behav 28:336-348.
84. Sapolsky RM (1992). Stress, the Aging Brain and the Mechanisms of Neuron Death. MIT Press, Cambridge, MA.
85. Forest MG, David M, Morel Y (1993). Prenatal diagnosis and treatment of 21-hydroxylase deficiency. J Steroid Biochem Mol Biol 45:75-82.
86. Mercado AB, Wilson RC, Cheng KC, Wei JQ, New MI (1995). Prenatal treatment and diagnosis of congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. J Clin Endocrinol Metab 80: 2014-2020.
87. Pang S, Clark AT, Freeman LC, Dolan LM, Immken L, Mueller OT, Stiff D, Shulman DI (1992). Maternal side-effects of prenatal dexamethasone therapy for fetal congenital adrenal hyperplasia. J Clin Endocrinol Metab 75:249-253.
88. Trautman PD, Meyer-Bahlburg HFL, Postelnek J, New MI (1995). Effects of early prenatal dexamethasone on the cognitive and behavioral development of young children: results of a pilot study. Psychoneuroendocrinology 20:439-449.